Singapore, Singapore

Michael A Crowe


 

Average Co-Inventor Count = 7.3

ph-index = 4

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Michael A Crowe: Innovator in Biocatalysis

Introduction

Michael A Crowe is a prominent inventor based in Singapore, SG. He has made significant contributions to the field of biocatalysis, holding a total of 13 patents. His work focuses on developing innovative methods and compounds that have applications in pharmaceuticals.

Latest Patents

Among his latest patents, Crowe has developed biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs. This patent provides engineered transaminase polypeptides for the production of amines, along with polynucleotides encoding these engineered transaminases. Additionally, he has created biocatalysts for the synthesis of Ezetimibe, which includes non-naturally occurring polypeptides useful for preparing this important pharmaceutical compound.

Career Highlights

Michael A Crowe is currently associated with Codexis, Inc., a company known for its innovative approaches in enzyme technology. His work at Codexis has allowed him to push the boundaries of biocatalysis and contribute to advancements in drug development.

Collaborations

Throughout his career, Crowe has collaborated with notable colleagues, including Derek J Smith and Shiwei Song. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Michael A Crowe's contributions to biocatalysis and his impressive portfolio of patents highlight his role as a leading inventor in the pharmaceutical industry. His work continues to pave the way for new advancements in drug synthesis and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…